Explore more topics
News sentiment

BioAge Labs, Inc. Common Stock (BIOA) news sentiment

How positive or negative BioAge Labs, Inc. Common Stock's news headlines have been since Sep 23, 2024, week by week, with the last 90 sessions day by day and each recent headline's tone and source.

As of 2026-10-29

Average tone, last 30 sessions
0From -100 (every headline negative) to +100 (every headline positive)
Headlines, last 30 sessions
9
Headlines, last 90 sessions
37
Change from the 90-session average
-15
Latest session
2026-10-29

Weekly headline tone since September 2024

Hover a week for its biggest stories; click to pin.

Tone8-week averageHeadlines
Every week since Sep 23, 2024
BIOA headline tone: Every week since Sep 23, 2024, 64 weeks from September 23, 2024 to October 12, 2026.-100-75-50-25+25+50+75+1000Headlines202420252026

Coverage of BioAge Labs, Inc. Common Stock over the last 30 trading sessions is neutral (0) across 9 headlines, 5 points above its one-year average of -5. The most widely carried story in the week of Oct 12, 2026 was "BioAge Labs (NASDAQ:BIOA) Stock Dropped to Strong Sell by Wall Street Zen", carried by 1 outlet.

Each point is one week of headlines about BioAge Labs, Inc. Common Stock: the share of positive minus negative headlines, from -100 to +100, with the 8-week average drawn through it and the number of headlines beneath. Since coverage began, 376 headlines average -6.

Jump to a section

Tone mix

BIOA headlines by tone, last 52 weeks
positive
11%
neutral
72%
negative
17%

Week by week 52 weeks

Jan 20, 2025: 0 positive, 14 neutral, 2 negativeJan 27, 2025: 0 positive, 12 neutral, 1 negativeFeb 3, 2025: 1 positive, 12 neutral, 1 negativeFeb 10, 2025: 0 positive, 15 neutral, 7 negativeFeb 17, 2025: 0 positive, 25 neutral, 13 negativeFeb 24, 2025: 0 positive, 29 neutral, 6 negativeMar 3, 2025: 0 positive, 40 neutral, 13 negativeMar 10, 2025: 0 positive, 17 neutral, 3 negativeMar 17, 2025: 0 positive, 1 neutral, 0 negativeApr 21, 2025: 1 positive, 0 neutral, 0 negativeMay 5, 2025: 1 positive, 0 neutral, 0 negativeMay 26, 2025: 1 positive, 1 neutral, 0 negativeJun 2, 2025: 0 positive, 1 neutral, 0 negativeJun 30, 2025: 0 positive, 1 neutral, 0 negativeAug 4, 2025: 0 positive, 2 neutral, 0 negativeAug 18, 2025: 0 positive, 1 neutral, 0 negativeOct 27, 2025: 0 positive, 0 neutral, 1 negativeNov 3, 2025: 0 positive, 1 neutral, 0 negativeNov 10, 2025: 1 positive, 2 neutral, 0 negativeNov 24, 2025: 0 positive, 1 neutral, 0 negativeDec 8, 2025: 1 positive, 2 neutral, 0 negativeDec 15, 2025: 0 positive, 0 neutral, 1 negativeDec 22, 2025: 0 positive, 1 neutral, 0 negativeJan 5, 2026: 1 positive, 0 neutral, 0 negativeJan 12, 2026: 0 positive, 2 neutral, 0 negativeJan 19, 2026: 3 positive, 0 neutral, 0 negativeJan 26, 2026: 0 positive, 2 neutral, 2 negativeFeb 16, 2026: 1 positive, 3 neutral, 0 negativeMar 2, 2026: 1 positive, 0 neutral, 0 negativeMar 9, 2026: 2 positive, 1 neutral, 0 negativeMar 16, 2026: 1 positive, 0 neutral, 0 negativeMar 30, 2026: 3 positive, 1 neutral, 0 negativeApr 13, 2026: 2 positive, 1 neutral, 0 negativeApr 20, 2026: 1 positive, 0 neutral, 0 negativeApr 27, 2026: 1 positive, 0 neutral, 0 negativeMay 11, 2026: 1 positive, 2 neutral, 0 negativeMay 18, 2026: 0 positive, 2 neutral, 0 negativeMay 25, 2026: 0 positive, 1 neutral, 0 negativeJun 8, 2026: 0 positive, 1 neutral, 0 negativeJun 15, 2026: 1 positive, 0 neutral, 0 negativeJun 29, 2026: 0 positive, 1 neutral, 0 negativeJul 13, 2026: 2 positive, 1 neutral, 0 negativeJul 20, 2026: 0 positive, 1 neutral, 0 negativeJul 27, 2026: 1 positive, 0 neutral, 0 negativeAug 3, 2026: 1 positive, 3 neutral, 1 negativeAug 31, 2026: 0 positive, 1 neutral, 0 negativeSep 7, 2026: 3 positive, 3 neutral, 1 negativeSep 14, 2026: 1 positive, 9 neutral, 0 negativeSep 21, 2026: 0 positive, 3 neutral, 0 negativeSep 28, 2026: 0 positive, 2 neutral, 0 negativeOct 5, 2026: 1 positive, 0 neutral, 0 negativeOct 12, 2026: 0 positive, 1 neutral, 1 negative
Jan 20, 2025Oct 12, 2026

Share of BioAge Labs, Inc. Common Stock's 305 headlines over the last 52 weeks by the model's call, and the same mix week by week.

Biggest swings in the last year

The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.

Daily headline tone, last 90 sessions

Hover a session for its totals; click to pin.

Session tone8-session averageHeadlines
Last 26 sessions with a headline
BIOA average headline tone by session: Last 26 sessions with a headline, 26 sessions from July 1, 2026 to October 16, 2026.-100-75-50-25+25+50+75+1000HeadlinesJul 2026AugSepOct

Each point is the average score of the headlines about BioAge Labs, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.

Tone by period

Show the table · 3 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Last 7 sessions0No headlines
Last 30 sessions90
Last 90 sessions37+15

Every headline in the period counts equally.

Headlines on Friday, October 16, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

BioAge Labs (NASDAQ:BIOA) & GSK (NYSE:GSK) Head-To-Head Analysiswww.themarketsdaily.com1Neutral

Headlines on Monday, October 12, 2026

1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

BioAge Labs (NASDAQ:BIOA) Stock Dropped to Strong Sell by Wall Street Zenwww.tickerreport.com1Negative

Headlines on Thursday, October 8, 2026

1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

BioAge Labs, Inc. (NASDAQ:BIOA) Stock Now Rated "Moderate Buy" by Sell-Side Analystswww.dailypolitical.com1Positive

Headlines on Thursday, October 1, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

BioAge Labs, Inc. (NASDAQ:BIOA) Stock Has Average Price Target of $36.57www.themarketsdaily.com1Neutral

Headlines on Monday, September 28, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

BioAge Labs to Present at Upcoming Investor Conferenceswww.manilatimes.net1Neutral

How the score works

A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.

  1. Which headlines count

    Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about BioAge Labs, Inc. Common Stock, not a passing mention.

  2. How each headline is scored

    The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).

  3. When a headline counts

    Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.

  4. Repeated stories

    When several outlets carry the same headline, it counts once per session.